Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Nerve | 14 | 2022 | 83 | 3.400 |
Why?
|
| Presbycusis | 7 | 2023 | 84 | 3.140 |
Why?
|
| Cochlea | 14 | 2023 | 169 | 2.780 |
Why?
|
| Hearing Loss, Sensorineural | 4 | 2021 | 110 | 1.930 |
Why?
|
| Spiral Ganglion | 8 | 2020 | 47 | 1.790 |
Why?
|
| Deafness | 3 | 2023 | 64 | 1.550 |
Why?
|
| Ouabain | 6 | 2016 | 32 | 1.210 |
Why?
|
| Neuroglia | 5 | 2018 | 136 | 1.170 |
Why?
|
| Myelin Sheath | 2 | 2021 | 115 | 1.140 |
Why?
|
| Ear, Inner | 5 | 2012 | 47 | 1.100 |
Why?
|
| Aging | 8 | 2022 | 911 | 1.020 |
Why?
|
| Mice, Inbred CBA | 10 | 2020 | 107 | 1.020 |
Why?
|
| Animals | 34 | 2023 | 20880 | 0.920 |
Why?
|
| Mice | 19 | 2023 | 8474 | 0.880 |
Why?
|
| Hearing Loss, Noise-Induced | 2 | 2018 | 46 | 0.850 |
Why?
|
| Hair Cells, Auditory | 6 | 2020 | 60 | 0.840 |
Why?
|
| Neurons | 7 | 2020 | 881 | 0.840 |
Why?
|
| Ranvier's Nodes | 1 | 2021 | 6 | 0.820 |
Why?
|
| Autistic Disorder | 1 | 2022 | 77 | 0.790 |
Why?
|
| Autism Spectrum Disorder | 1 | 2022 | 111 | 0.740 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2016 | 268 | 0.730 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 5 | 2022 | 49 | 0.690 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2019 | 16 | 0.680 |
Why?
|
| Disease Models, Animal | 9 | 2022 | 2550 | 0.670 |
Why?
|
| Neural Crest | 1 | 2019 | 58 | 0.670 |
Why?
|
| Mice, Quaking | 1 | 2018 | 12 | 0.630 |
Why?
|
| Hearing Loss, Central | 2 | 2015 | 9 | 0.620 |
Why?
|
| Demyelinating Diseases | 1 | 2018 | 57 | 0.610 |
Why?
|
| Vestibulocochlear Nerve Diseases | 1 | 2016 | 10 | 0.560 |
Why?
|
| Gerbillinae | 6 | 2010 | 156 | 0.540 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 215 | 0.540 |
Why?
|
| Round Window, Ear | 2 | 2014 | 8 | 0.530 |
Why?
|
| Vestibulocochlear Nerve Injuries | 2 | 2013 | 2 | 0.520 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 32 | 0.520 |
Why?
|
| Stria Vascularis | 3 | 2023 | 31 | 0.510 |
Why?
|
| Stem Cells | 2 | 2015 | 248 | 0.500 |
Why?
|
| SOXE Transcription Factors | 1 | 2014 | 9 | 0.480 |
Why?
|
| Genetic Therapy | 2 | 2020 | 291 | 0.480 |
Why?
|
| Nerve Degeneration | 2 | 2013 | 134 | 0.480 |
Why?
|
| Heptanol | 1 | 2014 | 2 | 0.470 |
Why?
|
| Hearing Loss, Conductive | 1 | 2014 | 12 | 0.470 |
Why?
|
| Hearing | 2 | 2020 | 133 | 0.430 |
Why?
|
| Gentamicins | 3 | 1997 | 68 | 0.410 |
Why?
|
| Myelin Basic Protein | 1 | 2012 | 62 | 0.410 |
Why?
|
| Enzyme Inhibitors | 5 | 2013 | 659 | 0.410 |
Why?
|
| Auditory Threshold | 7 | 2020 | 206 | 0.400 |
Why?
|
| Chemokine CXCL12 | 1 | 2011 | 51 | 0.390 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2011 | 20 | 0.390 |
Why?
|
| Cochlear Duct | 1 | 2011 | 5 | 0.380 |
Why?
|
| Dependovirus | 1 | 2011 | 34 | 0.380 |
Why?
|
| Mice, Congenic | 1 | 2010 | 13 | 0.370 |
Why?
|
| Action Potentials | 4 | 2010 | 223 | 0.370 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 173 | 0.360 |
Why?
|
| Genetic Vectors | 1 | 2011 | 311 | 0.350 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2016 | 245 | 0.350 |
Why?
|
| NF-kappa B | 3 | 2006 | 432 | 0.340 |
Why?
|
| Macrophages | 2 | 2023 | 647 | 0.320 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 40 | 0.310 |
Why?
|
| Vestibule, Labyrinth | 3 | 2012 | 19 | 0.310 |
Why?
|
| Hearing Loss | 1 | 2011 | 154 | 0.310 |
Why?
|
| Stem Cell Transplantation | 1 | 2008 | 58 | 0.310 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1174 | 0.300 |
Why?
|
| Immunohistochemistry | 4 | 2018 | 1174 | 0.290 |
Why?
|
| Apoptosis | 4 | 2013 | 1641 | 0.290 |
Why?
|
| Male | 14 | 2023 | 37283 | 0.280 |
Why?
|
| Female | 14 | 2023 | 38021 | 0.280 |
Why?
|
| Humans | 14 | 2023 | 68549 | 0.260 |
Why?
|
| Anti-Bacterial Agents | 3 | 1997 | 1026 | 0.260 |
Why?
|
| Aged | 5 | 2023 | 14842 | 0.230 |
Why?
|
| Chick Embryo | 2 | 2001 | 379 | 0.210 |
Why?
|
| MEF2 Transcription Factors | 1 | 2022 | 36 | 0.210 |
Why?
|
| Cell Differentiation | 3 | 2016 | 1034 | 0.210 |
Why?
|
| Epithelial Cells | 3 | 2004 | 431 | 0.210 |
Why?
|
| Reference Values | 2 | 2014 | 579 | 0.200 |
Why?
|
| Random Allocation | 2 | 2014 | 442 | 0.200 |
Why?
|
| Immunity | 1 | 2021 | 67 | 0.190 |
Why?
|
| Cells, Cultured | 3 | 2015 | 2673 | 0.190 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2014 | 72 | 0.190 |
Why?
|
| Axons | 1 | 2021 | 139 | 0.190 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 1293 | 0.190 |
Why?
|
| Neurotrophin 3 | 1 | 2020 | 7 | 0.180 |
Why?
|
| Mesoderm | 1 | 2001 | 231 | 0.180 |
Why?
|
| Noise | 1 | 2020 | 153 | 0.170 |
Why?
|
| Sarcoma, Kaposi | 1 | 1999 | 24 | 0.170 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2020 | 124 | 0.160 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1999 | 36 | 0.160 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 1033 | 0.160 |
Why?
|
| Ear Diseases | 1 | 1997 | 37 | 0.150 |
Why?
|
| Furosemide | 2 | 2010 | 45 | 0.140 |
Why?
|
| Inflammation | 1 | 2023 | 1030 | 0.140 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2016 | 21 | 0.140 |
Why?
|
| Antigens, CD34 | 1 | 2016 | 75 | 0.140 |
Why?
|
| Middle Aged | 4 | 2023 | 21119 | 0.140 |
Why?
|
| Fetal Blood | 1 | 2016 | 131 | 0.140 |
Why?
|
| Hair Cells, Vestibular | 1 | 1996 | 6 | 0.140 |
Why?
|
| Saccule and Utricle | 1 | 1996 | 7 | 0.140 |
Why?
|
| Vestibular Function Tests | 1 | 1996 | 5 | 0.140 |
Why?
|
| Adult Stem Cells | 1 | 2015 | 13 | 0.130 |
Why?
|
| Nerve Regeneration | 1 | 2015 | 42 | 0.130 |
Why?
|
| Quality of Life | 1 | 2023 | 1515 | 0.120 |
Why?
|
| Carbonic Anhydrase III | 1 | 2014 | 3 | 0.120 |
Why?
|
| Spiral Ligament of Cochlea | 1 | 2014 | 3 | 0.120 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2012 | 127 | 0.120 |
Why?
|
| Temporal Bone | 1 | 2014 | 53 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 4843 | 0.110 |
Why?
|
| Cell Death | 2 | 2008 | 329 | 0.110 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2013 | 35 | 0.110 |
Why?
|
| Ribose-Phosphate Pyrophosphokinase | 1 | 2012 | 1 | 0.110 |
Why?
|
| Tissue Donors | 1 | 2014 | 195 | 0.110 |
Why?
|
| Imidazoles | 1 | 2013 | 175 | 0.100 |
Why?
|
| Cellular Senescence | 1 | 2013 | 112 | 0.100 |
Why?
|
| Guinea Pigs | 3 | 1997 | 124 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 196 | 0.100 |
Why?
|
| Piperazines | 1 | 2013 | 206 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 231 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2011 | 242 | 0.100 |
Why?
|
| Synapses | 1 | 2013 | 222 | 0.100 |
Why?
|
| Ganglia, Sensory | 2 | 2001 | 2 | 0.090 |
Why?
|
| Transduction, Genetic | 1 | 2011 | 81 | 0.090 |
Why?
|
| Perilymph | 2 | 2008 | 6 | 0.090 |
Why?
|
| Acoustic Stimulation | 2 | 2022 | 206 | 0.090 |
Why?
|
| Schwann Cells | 1 | 2010 | 33 | 0.090 |
Why?
|
| Neuronal Plasticity | 1 | 2013 | 274 | 0.090 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2010 | 11 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 181 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2011 | 954 | 0.080 |
Why?
|
| Whole-Body Irradiation | 2 | 2006 | 52 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 189 | 0.080 |
Why?
|
| Fibroblasts | 2 | 2006 | 902 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2011 | 682 | 0.080 |
Why?
|
| Endolymph | 1 | 2008 | 6 | 0.080 |
Why?
|
| Neurons, Afferent | 1 | 2008 | 32 | 0.080 |
Why?
|
| Bromodeoxyuridine | 2 | 2000 | 37 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2012 | 447 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 1 | 2008 | 164 | 0.070 |
Why?
|
| Cell Division | 2 | 2000 | 541 | 0.070 |
Why?
|
| Mitomycin | 1 | 2006 | 27 | 0.070 |
Why?
|
| Ear, Middle | 1 | 2006 | 32 | 0.070 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 2006 | 10 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2012 | 2791 | 0.070 |
Why?
|
| Radiation Chimera | 1 | 2006 | 15 | 0.070 |
Why?
|
| Propidium | 1 | 2006 | 26 | 0.070 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2006 | 82 | 0.070 |
Why?
|
| Colony-Forming Units Assay | 1 | 2006 | 78 | 0.070 |
Why?
|
| Leukocyte Common Antigens | 1 | 2006 | 41 | 0.070 |
Why?
|
| Cell Count | 1 | 2006 | 248 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 200 | 0.070 |
Why?
|
| Collagen Type XI | 1 | 2005 | 3 | 0.060 |
Why?
|
| Calcineurin | 1 | 2005 | 13 | 0.060 |
Why?
|
| Graft Survival | 1 | 2008 | 465 | 0.060 |
Why?
|
| Cytochromes c | 1 | 2005 | 75 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 179 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2006 | 396 | 0.060 |
Why?
|
| Transcription Factor RelA | 1 | 2005 | 47 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2006 | 489 | 0.060 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2005 | 47 | 0.060 |
Why?
|
| Biomarkers | 1 | 2010 | 1593 | 0.060 |
Why?
|
| Caspases | 1 | 2005 | 194 | 0.060 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2004 | 22 | 0.060 |
Why?
|
| Radiation Tolerance | 1 | 2004 | 30 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2005 | 233 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 1172 | 0.060 |
Why?
|
| Intestine, Small | 1 | 2004 | 89 | 0.060 |
Why?
|
| Proadifen | 1 | 2002 | 4 | 0.050 |
Why?
|
| Gap Junctions | 1 | 2002 | 29 | 0.050 |
Why?
|
| Cell Survival | 1 | 2005 | 901 | 0.050 |
Why?
|
| Brain Stem | 1 | 2022 | 46 | 0.050 |
Why?
|
| Time Factors | 3 | 2013 | 4655 | 0.050 |
Why?
|
| Vestibulocochlear Nerve | 1 | 2001 | 17 | 0.050 |
Why?
|
| Retroviridae | 1 | 2001 | 29 | 0.050 |
Why?
|
| Clone Cells | 1 | 2001 | 67 | 0.050 |
Why?
|
| Cartilage | 1 | 2001 | 51 | 0.050 |
Why?
|
| Auditory Perception | 1 | 2022 | 89 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2001 | 146 | 0.050 |
Why?
|
| Europe | 1 | 1999 | 196 | 0.040 |
Why?
|
| Digoxigenin | 1 | 1997 | 2 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 85 | 0.040 |
Why?
|
| Cell Size | 1 | 1997 | 76 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 1997 | 32 | 0.040 |
Why?
|
| Labyrinth Supporting Cells | 1 | 1996 | 4 | 0.030 |
Why?
|
| Incidence | 1 | 1999 | 1582 | 0.030 |
Why?
|
| Adult | 1 | 2012 | 21379 | 0.030 |
Why?
|
| Organ of Corti | 1 | 2013 | 21 | 0.030 |
Why?
|
| Receptors, Glutamate | 1 | 2013 | 22 | 0.030 |
Why?
|
| Presynaptic Terminals | 1 | 2013 | 34 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2013 | 24 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 51 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2013 | 37 | 0.030 |
Why?
|
| Hair Cells, Auditory, Inner | 1 | 2012 | 19 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 97 | 0.030 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 2 | 2002 | 19 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 201 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 209 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 1851 | 0.020 |
Why?
|
| Audiometry, Evoked Response | 1 | 2006 | 8 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2006 | 111 | 0.020 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2004 | 12 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 2689 | 0.010 |
Why?
|
| Time | 1 | 2002 | 57 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2002 | 26 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2002 | 160 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 2002 | 61 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 351 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1745 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2004 | 1692 | 0.010 |
Why?
|